top of page


News​


Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Alpha DaRTâ„¢ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Nov 26, 2019


Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer
Proceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for...
Sep 5, 2018

CEO Uzi Sofer Reveals Great News on Galatz Radio 02.07.2018
Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for...
Jul 15, 2018


Alpha Particles Treat Deeper Into Solid Tumors
View article here
May 4, 2018


May the New Year Begin- Happy Rosh HaShana!
After an exiting year of significant progress in research and development, Uzi Sofer invited the whole team to his house in Jerusalem....
Sep 20, 2017
bottom of page